BR0306927A - Compostos tricìclicos de 2-pirimidona úteis como inibidores de transcriptase reversa de hiv - Google Patents

Compostos tricìclicos de 2-pirimidona úteis como inibidores de transcriptase reversa de hiv

Info

Publication number
BR0306927A
BR0306927A BR0306927-3A BR0306927A BR0306927A BR 0306927 A BR0306927 A BR 0306927A BR 0306927 A BR0306927 A BR 0306927A BR 0306927 A BR0306927 A BR 0306927A
Authority
BR
Brazil
Prior art keywords
reverse transcriptase
transcriptase inhibitors
hiv reverse
tricyclic
compounds useful
Prior art date
Application number
BR0306927-3A
Other languages
English (en)
Inventor
Christine M Tarby
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of BR0306927A publication Critical patent/BR0306927A/pt

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • AIDS & HIV (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

"COMPOSTOS TRICìCLICOS DE 2-PIRIMIDONA úTEIS COMO INIBIDORES DE TRANSCRIPTASE REVERSA DE HIV". A presente invenção se refere a compostos tricíclicos de 2-pirimidona de fórmula (I), ou a suas formas estereoisoméricas, misturas de formas estereoisoméricas, ou a formas de sais farmaceuticamente aceitáveis, que são úteis como inibidores de transcriptase reversa de HIV, e a composições farmacêuticas e a kits diagnósticos compreendendo os mesmos, e a processos de emprego dos mesmos para o tratamento de infecção viral ou como um padrão ou reagente para ensaios.
BR0306927-3A 2002-01-18 2003-01-16 Compostos tricìclicos de 2-pirimidona úteis como inibidores de transcriptase reversa de hiv BR0306927A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US34964102P 2002-01-18 2002-01-18
PCT/US2003/001604 WO2003062238A1 (en) 2002-01-18 2003-01-16 Tricyclic 2-pyrimidone compounds useful as hiv reverse transcriptase inhibitors

Publications (1)

Publication Number Publication Date
BR0306927A true BR0306927A (pt) 2004-11-09

Family

ID=27613304

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0306927-3A BR0306927A (pt) 2002-01-18 2003-01-16 Compostos tricìclicos de 2-pirimidona úteis como inibidores de transcriptase reversa de hiv

Country Status (21)

Country Link
US (2) US6844340B2 (pt)
EP (1) EP1474424A4 (pt)
JP (1) JP2005519910A (pt)
KR (1) KR20040077735A (pt)
CN (1) CN1642954A (pt)
AR (1) AR038164A1 (pt)
BR (1) BR0306927A (pt)
CA (1) CA2473420A1 (pt)
CO (1) CO5590961A2 (pt)
HR (1) HRP20040643A2 (pt)
IL (1) IL162743A0 (pt)
IS (1) IS7341A (pt)
MX (1) MXPA04006948A (pt)
NO (1) NO20043424L (pt)
PE (1) PE20030987A1 (pt)
PL (1) PL371418A1 (pt)
RU (1) RU2004125151A (pt)
TW (1) TW200306192A (pt)
WO (1) WO2003062238A1 (pt)
YU (1) YU62504A (pt)
ZA (1) ZA200405139B (pt)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7169932B2 (en) 2001-06-11 2007-01-30 Pfizer Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses, material for their synthesis
US7094909B2 (en) 2001-06-11 2006-08-22 Agouron Pharmaceuticals, Inc. HIV protease inhibitors, compositions containing the same, their pharmaceutical uses and materials for their synthesis
HN2002000136A (es) 2001-06-11 2003-07-31 Basf Ag Inhibidores de la proteasa del virus hiv, compuestos que contienen a los mismos, sus usos farmaceuticos y los materiales para su sintesis
TW200306192A (en) * 2002-01-18 2003-11-16 Bristol Myers Squibb Co Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors
AR039540A1 (es) 2002-05-13 2005-02-23 Tibotec Pharm Ltd Compuestos microbicidas con contenido de pirimidina o triazina
MXPA05008364A (es) 2003-02-07 2005-11-04 Janssen Pharmaceutica Nv Derivados de pirimidina para la prevencion de una infeccion por vih.
WO2008004100A2 (en) 2006-07-05 2008-01-10 Pfizer Products Inc. Therapeutic compounds
US20080119552A1 (en) * 2006-11-17 2008-05-22 Novus International Inc. Matrix-embedded compositions having organic acids and fatty acids
JP5406215B2 (ja) 2008-01-25 2014-02-05 ハイ ポイント ファーマシューティカルズ,リミティド ライアビリティ カンパニー TNF−α合成の調節因子及びPDE4阻害剤としての三環系化合物
WO2011076765A1 (en) 2009-12-23 2011-06-30 Katholieke Universiteit Leuven Novel antiviral compounds
WO2012065963A2 (en) 2010-11-15 2012-05-24 Katholieke Universiteit Leuven Novel antiviral compounds
EP2640729B1 (en) 2010-11-15 2016-12-21 VIIV Healthcare UK Limited Inhibitors of hiv replication
CN103130787B (zh) * 2011-11-24 2015-06-10 南开大学 嘧啶酮酰胺类化合物及其制备方法、抗hiv活性和抗tmv活性

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6593337B1 (en) * 1999-10-19 2003-07-15 Bristol-Myers Squibb Pharma Company Tricyclic compounds useful as HIV reverse transcriptase inhibitors
US6596729B2 (en) 2000-07-20 2003-07-22 Bristol-Myers Squibb Company Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors
TW200306192A (en) * 2002-01-18 2003-11-16 Bristol Myers Squibb Co Tricyclic 2-pyrimidone compounds useful as HIV reverse transcriptase inhibitors

Also Published As

Publication number Publication date
ZA200405139B (en) 2006-02-22
PE20030987A1 (es) 2003-11-15
HRP20040643A2 (en) 2005-04-30
CO5590961A2 (es) 2005-12-30
YU62504A (sh) 2006-08-17
NO20043424L (no) 2004-08-18
WO2003062238A1 (en) 2003-07-31
JP2005519910A (ja) 2005-07-07
US7186830B2 (en) 2007-03-06
IL162743A0 (en) 2005-11-20
AR038164A1 (es) 2004-12-29
US20030162800A1 (en) 2003-08-28
MXPA04006948A (es) 2004-12-06
US20040266778A1 (en) 2004-12-30
US6844340B2 (en) 2005-01-18
CA2473420A1 (en) 2003-07-31
PL371418A1 (en) 2005-06-13
IS7341A (is) 2004-06-30
EP1474424A1 (en) 2004-11-10
CN1642954A (zh) 2005-07-20
RU2004125151A (ru) 2006-02-20
EP1474424A4 (en) 2005-12-28
TW200306192A (en) 2003-11-16
KR20040077735A (ko) 2004-09-06

Similar Documents

Publication Publication Date Title
BR0015056A (pt) Composto, uso de um composto, composição farmacêutica, método de tratamento de infecções por hiv e kit farmacêutico
BRPI0413469A (pt) derivados de piperazina para o tratamento de infecções por hiv
BRPI0413452A (pt) composto, composição farmacêutica, kit, artigo de fabricação, e, métodos de inibir dpp-iv, terapêutico e de tratar um estado de doença, cáncer, distúrbios autoimunes, uma condição einfecção por hiv
BRPI0212726B8 (pt) compostos contendo lactamas, e derivados dos mesmos, composição farmacêutica que os compreende e seus usos
EA200802209A1 (ru) Ингибиторы репликации вируса иммунодефицита человека
HN2003000348A (es) Compuestos de benzofurano, composiciones y metodos para tratamiento y profilaxis de infeccion virales de hepatitis c y enfermedades asociadas.
BR0312560A (pt) Novas espiropiperidinas ou espiropirrolidinas tricìclicas
BR0306927A (pt) Compostos tricìclicos de 2-pirimidona úteis como inibidores de transcriptase reversa de hiv
EA200401436A1 (ru) Ингибиторы протеазы вич для лечения инфекции вич и фармацевтическая композиция
BR0316386A (pt) Benzoxazin-3-onas e seus derivados como inibidores de p13k
BRPI0418099A (pt) compostos, composição farmacêutica, e uso de um composto
BRPI0412291A (pt) antagonistas duplos de nka/nk3 para o tratamento de esquizofrenia
BRPI0408767A (pt) inibidores de transcriptase reversa não-nucleosìdeos i para o tratamento de doenças mediadas pelo hiv
BRPI0608245A2 (pt) compostos; processo para a sua fabricação; composições farmacêuticas; método para o tratamento e/ou prevenção de doenças que estejam associadas à modulação de receptores de sst subtipo 5 e uso dos compostos
BRPI0407591A (pt) inibidores de transcriptase reversa de não-nucleosìdeo
BR9813651A (pt) Compostos antipicornavirais e métodos para o seu uso e preparação
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
BRPI0414948A (pt) derivados de pirazolo-e-imidazo pirimidina
BRPI0514724A (pt) inibidores da enzima hiv integrase
BR0208987A (pt) Composto tricìclicos úteis como inibidores de transcriptase reserva de hiv
BRPI0509667B8 (pt) composto, processo para a preparação de um composto de fórmula (i), medicamento e uso de um composto
TW200710091A (en) (1,10B-dihydro-2-(aminoalkyl-phenyl)-5H-pyrazolo [1,5-c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as HIV viral replication inhibitors
BR0308786A (pt) Derivados de ftalimido como inibidores da monoamina oxidase b
WO2005105810A3 (en) (1,10b-dihydro-2-(aminocarbonyl-phenyl)-5h-pyrazolo[1,5- c][1,3]benzoxazin-5-yl)phenyl methanone derivatives as hiv viral replication inhibitors
BR0112606A (pt) Compostos tricìclicos 2-piridona úteis como inibidores de transcriptase inversa de hiv

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 6O E 7O ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2047 DE 30/03/2010.